Ying‐Hsia Shih

663 total citations
19 papers, 557 citations indexed

About

Ying‐Hsia Shih is a scholar working on Biomedical Engineering, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ying‐Hsia Shih has authored 19 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomedical Engineering, 7 papers in Biomaterials and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ying‐Hsia Shih's work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Ying‐Hsia Shih is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (7 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Ying‐Hsia Shih collaborates with scholars based in Taiwan. Ying‐Hsia Shih's co-authors include Cheng‐Liang Peng, Ming‐Jium Shieh, Tsai‐Yueh Luo, Pei‐Chi Lee, Thomas Mon-Hsian Hsieh, Wuu‐Jyh Lin, Cheng-Jung Yao, Ming-Hsien Tsai, Shin‐Yu Lee and Ming‐Feng Wei and has published in prestigious journals such as ACS Nano, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Ying‐Hsia Shih

18 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying‐Hsia Shih Taiwan 11 363 228 132 128 104 19 557
Brian Wan-Chi Tse Australia 13 414 1.1× 214 0.9× 210 1.6× 169 1.3× 172 1.7× 24 822
Hohyeon Lee South Korea 13 433 1.2× 149 0.7× 188 1.4× 82 0.6× 127 1.2× 23 631
Guobin Hong China 17 326 0.9× 167 0.7× 100 0.8× 90 0.7× 118 1.1× 35 675
John Richey United States 7 239 0.7× 284 1.2× 152 1.2× 145 1.1× 100 1.0× 10 613
Jianli Ren China 15 501 1.4× 193 0.8× 171 1.3× 69 0.5× 117 1.1× 25 667
Hyounkoo Han South Korea 16 475 1.3× 275 1.2× 235 1.8× 79 0.6× 145 1.4× 21 869
Lei Xia China 15 307 0.8× 100 0.4× 121 0.9× 125 1.0× 166 1.6× 35 703
Jueun Jeon South Korea 18 482 1.3× 316 1.4× 269 2.0× 89 0.7× 174 1.7× 27 913
Jeane Chen United States 12 209 0.6× 186 0.8× 141 1.1× 67 0.5× 77 0.7× 13 629
Tsai‐Yueh Luo Taiwan 18 452 1.2× 378 1.7× 204 1.5× 183 1.4× 125 1.2× 37 915

Countries citing papers authored by Ying‐Hsia Shih

Since Specialization
Citations

This map shows the geographic impact of Ying‐Hsia Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Hsia Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Hsia Shih more than expected).

Fields of papers citing papers by Ying‐Hsia Shih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Hsia Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Hsia Shih. The network helps show where Ying‐Hsia Shih may publish in the future.

Co-authorship network of co-authors of Ying‐Hsia Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Hsia Shih. A scholar is included among the top collaborators of Ying‐Hsia Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Hsia Shih. Ying‐Hsia Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chang, Ming‐Cheng, Cheng‐Liang Peng, Chun-Tang Chen, et al.. (2024). Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review. Pharmaceuticals. 17(12). 1563–1563. 4 indexed citations
3.
Wu, Cheng‐Tien, Cheng‐Liang Peng, Ying‐Hsia Shih, et al.. (2021). A novel 111indium-labeled dual carbonic anhydrase 9-targeted probe as a potential SPECT imaging radiotracer for detection of hypoxic colorectal cancer cells. European Journal of Pharmaceutics and Biopharmaceutics. 168. 38–52. 4 indexed citations
4.
Peng, Cheng‐Liang, et al.. (2021). Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy. International Journal of Molecular Sciences. 22(22). 12214–12214. 10 indexed citations
5.
Peng, Cheng‐Liang, Wei‐Lun Chiang, Ying‐Hsia Shih, et al.. (2018). Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer. Photodiagnosis and Photodynamic Therapy. 23. 111–118. 30 indexed citations
6.
Peng, Cheng‐Liang, et al.. (2018). Biodegradable and Multifunctional Microspheres for Treatment of Hepatoma through Transarterial Embolization. ACS Biomaterials Science & Engineering. 4(9). 3425–3433. 26 indexed citations
7.
Tsai, Ming-Hsien, Cheng‐Liang Peng, Ying‐Hsia Shih, et al.. (2018). pH-Responsive Nanophotosensitizer for an Enhanced Photodynamic Therapy of Colorectal Cancer Overexpressing EGFR. Molecular Pharmaceutics. 15(4). 1432–1444. 20 indexed citations
8.
Shih, Ying‐Hsia, Tsai‐Yueh Luo, Cheng-Jung Yao, et al.. (2017). EGFR-targeted micelles containing near-infrared dye for enhanced photothermal therapy in colorectal cancer. Journal of Controlled Release. 258. 196–207. 43 indexed citations
9.
Lee, Shin‐Yu, Ming‐Feng Wei, Cheng‐Liang Peng, et al.. (2016). Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles. ACS Applied Materials & Interfaces. 8(28). 17793–17804. 91 indexed citations
10.
Shih, Ying‐Hsia, et al.. (2015). Therapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinoma. International Journal of Nanomedicine. 10. 7443–7443. 23 indexed citations
11.
Peng, Cheng‐Liang, Pei‐Chi Lee, Ming‐Hsien Tsai, et al.. (2015). Traceable Self‐Assembly of Laser‐Triggered Cyanine‐Based Micelle for Synergistic Therapeutic Effect. Advanced Healthcare Materials. 4(6). 892–902. 22 indexed citations
12.
Shih, Ying‐Hsia, Cheng‐Liang Peng, Shin‐Yu Lee, et al.. (2015). 111In-cetuximab as a diagnostic agent by accessible epidermal growth factor (EGF) receptor targeting in human metastatic colorectal carcinoma. Oncotarget. 6(18). 16601–16610. 17 indexed citations
13.
Peng, Cheng‐Liang, Ying‐Hsia Shih, Xi‐Zhang Lin, et al.. (2014). Preparation and therapeutic evaluation of 188Re-thermogelling emulsion in rat model of hepatocellular carcinoma. International Journal of Nanomedicine. 9. 4191–4191. 5 indexed citations
14.
Luo, Tsai‐Yueh, et al.. (2013). Development of in-situ forming thermosensitive hydrogel for radiotherapy combined with chemotherapy in a mouse model of hepatocellular carcinoma. 54. 1319–1319. 2 indexed citations
15.
Peng, Cheng‐Liang, Ying‐Hsia Shih, Chung‐Hsin Yeh, et al.. (2013). Development of in Situ Forming Thermosensitive Hydrogel for Radiotherapy Combined with Chemotherapy in a Mouse Model of Hepatocellular Carcinoma. Molecular Pharmaceutics. 10(5). 1854–1864. 45 indexed citations
16.
Peng, Cheng‐Liang, Ying‐Hsia Shih, Pei‐Chi Lee, et al.. (2011). Multimodal Image-Guided Photothermal Therapy Mediated by188Re-Labeled Micelles Containing a Cyanine-Type Photosensitizer. ACS Nano. 5(7). 5594–5607. 193 indexed citations
17.
Luo, Tsai‐Yueh, et al.. (2009). Evaluating the Potential of 188 Re-ECD/Lipiodol as a Therapeutic Radiopharmaceutical by Intratumoral Injection for Hepatoma Treatment. Cancer Biotherapy and Radiopharmaceuticals. 24(5). 535–541. 11 indexed citations
18.
Lee, Chen‐Yi, et al.. (2007). Localized heating of tumor cells utilizing superparamagnetic nanoparticles. 44. 969–974. 1 indexed citations
19.
Lee, Chen‐Yi, et al.. (2007). Hyperthermia Cancer Therapy Utilizing Superparamagnetic Nanoparticles. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026